Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Influenza

This chapter highlights the comprehensive role of pharmacists in managing influenza through clinical, economic, and humanistic dimensions. Clinically, pharmacists contribute to influenza prevention, early detection, vaccination services, medication optimization, patient counseling, and supportive care—resulting in reduced disease severity, complications, and improved outcomes. Economically, pharmacist-led interventions lower healthcare costs by minimizing hospitalizations, optimizing medication use, promoting generics, and improving public awareness. Their accessibility and cost-effective vaccination efforts enhance community-level disease control. From a humanistic perspective, pharmacists improve patients’ quality of life by ensuring treatment adherence, enhancing health literacy, and empowering patients to adopt preventive behaviors. Patient satisfaction is increased through accessible, trust-based, and personalized care. Despite barriers such as regulatory limitations and lack of reimbursement models, pharmacists remain integral to influenza management. Their role is vital in reducing global influenza burden and underscores the need for policy support, collaborative practice, and expanded responsibilities in public health.